Table 1 Clinical characteristics of included individuals in cross-sectional studies.

From: Differentially expressed circulating LncRNAs and mRNA identified by microarray analysis in obese patients

 

Nonobese (n = 33)

Obese (n = 33)

p

Age (years)

41.00 ± 12.71

35.77 ± 11.69

0.206

Sex (male/female)

17/16

17/16

1.000

BMI (kg/m2)

21.75 ± 1.74

32.66 ± 4.45

0.000

Waist circumference (cm)

76.22 ± 6.07

112.58 ± 11.14

0.000

Waist-hip Ratio

0.82 ± 0.05

0.96 ± 0.05

0.000

Fasting glucose (mmo/L)

4.83 ± 0.57

5.08 ± 0.54

0.045

Fasting insulin (ÎĽU/mL)

6.47 ± 3.24

16.85 ± 9.35

0.002

Fasting C-peptide (ng/mL)

1.58 ± 0.40

3.52 ± 1.45

0.001

HOMA-β (%)

136.52 ± 153.12

197.32 ± 113.96

0.260

HOMA-IR

1.42 ± 0.84

4.73 ± 2.45

0.001

Total cholesterol (mg/dL)

4.70 ± 0.78

4.87 ± 1.85

0.767

Fasting triglycerides (mg/dL)

1.43 ± 1.00

2.32 ± 1.09

0.040

HDL cholesterol (mg/dL)

1.39 ± 0.38

1.11 ± 0.22

0.031

LDL cholesterol (mg/dL)

3.04 ± 0.74

3.58 ± 1.17

0.170

IL-6 (Pg/ml)

4.52 ± 3.86

5.49 ± 4.07

0.636

CRP (mg/dl)

4.28 ± 8.49

6.46 ± 8.67

0.557

Fatty liver (%)

16.4%

78.9%

0.006

Back to article page